Home News Professional Young Breast Cancer Patients Face Higher Risk for Osteoporosis WEDNESDAY, Dec. 12, 2018 — The risk for bone loss rises sharply in young breast cancer patients who received standard treatment, according to a study recently published in Breast Cancer Research. Cody Ramin, Ph.D., from Johns Hopkins University in Baltimore, and colleagues prospectively […]Continue Reading ...
Unraveling the complexity of cancer biology can lead to the identification of new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems to be a way to do it. “Our approach to finding new treatments for cancer is to conduct integrated analyses of multiple components […]Continue Reading ...
Breast cancer risk remains elevated 20-30 years after childbirth In general, women who have had children have a lower risk of breast cancer compared to women who have never given birth. However, new research has found that moms don’t experience this breast cancer protection until many years later and may face elevated risk for more […]Continue Reading ...
FRIDAY, Dec. 7, 2018 — There’s more evidence that when a survivor of early stage breast cancer takes up healthy eating and regular exercise, the odds of the disease returning go down. The key is sticking with such programs, said study lead author Dr. Wolfgang Janni. Healthier lifestyles “might improve the prognosis of breast cancer […]Continue Reading ...
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers. New research from two studies conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania, are […]Continue Reading ...
Multigene tests have been used in breast cancer treatment to assess the risk of metastasis for several years. A team at the Breast Cancer Center at the Technical University of Munich’s (TUM) Klinikum rechts der Isar has now presented results based on data collected in its routine clinical work. These results show that the multigene […]Continue Reading ...
Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better cardiovascular function than those who were not part of the exercise program, according to results of the EBBA-II trial presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8. “Breast cancer survival rates have improved, but many […]Continue Reading ...
Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly higher breast cancer recurrence and increased overall mortality compared to white women in a large phase III clinical trial, TAILORx, according to data presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8. “Our findings are consistent […]Continue Reading ...
FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin INCHEON, South Korea & JERUSALEM–(BUSINESS WIRE) December 14, 2018 –Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Herzuma (trastuzumab-pkrb), a HER2/neu receptor antagonist biosimilar to Herceptin®1 (trastuzumab) for the following indications: Adjuvant Breast Cancer of HER2 […]Continue Reading ...
An analysis of race and ethnicity data from the TAILORx clinical trial was presented at the 2018 San Antonio Breast Cancer Symposium. The new study confirms that women of all races and ethnicities can safely follow the TAILORx findings (above and here). However, the study also found that after nine years of follow-up, 83.1 percent […]Continue Reading ...
Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod, a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this first-of-its-kind system, which was invented by University of Maryland School of Medicine (UMSOM) […]Continue Reading ...
Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. These findings were presented at the 2018 San Antonio Breast Cancer […]Continue Reading ...
Novel device aims to shorten treatment, possibly eliminate surgery for early-stage breast cancer Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer. The UMGCCC is the first site to treat patients with this […]Continue Reading ...
Even as more young women with breast cancer opt to have mastectomies, many experience a persistent decline in their sexual and psychosocial well-being following the procedure, as detailed in new research by Dana-Farber/Brigham and Women’s Cancer Center. The findings, to be presented today at the San Antonio Breast Cancer Symposium, underscore the importance of counseling […]Continue Reading ...
A team of surgeons from the Perelman School of Medicine at the University of Pennsylvania are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction – a procedure in which tissue is taken from the lower abdomen – similar to a “tummy tuck” – and […]Continue Reading ...
- Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy
- Studies reveal role of red meat in gut bacteria, heart disease development
- Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin
- Researchers use brain connectome to reassess neuroimaging findings of Alzheimer’s disease
- “Miracle” baby survives Ebola in Congo and rapid a new Ebola detection device
- Study finds misuse of benzodiazepines to be highest among young adults
- TGen receives PayPal grant to underwrite costs of genetic tests for children with rare disorders
- New research highlights why HIV-infected patients suffer higher rates of cancer
- Antibiotic-resistant bacteria could soon be targeted with Alzheimer’s drug
- Rutgers scientists take an important step in making diseased hearts heal themselves
- Tailored Feedback at CRC Screen Improves Lifestyle Behaviors
- Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
- How the Mediterranean Diet Can Help Women’s Hearts
- Sustained connections associated with symptoms of autism
- Concussion rates among young football players were higher than previously reported
- Cresco Labs granted approval to operate marijuana dispensary in Ohio
- Study provides insight into health risks facing new mothers
- AMSBIO expands Wnt signaling pathway product range to aid research
- Surgical treatment unnecessary for many prostate cancer patients
- Excess weight responsible for cancers globally finds report